Mic Iwashima
Chief Operating Officer chez SATSUMA PHARMACEUTICALS, INC.
Postes actifs de Mic Iwashima
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SATSUMA PHARMACEUTICALS, INC. | Chief Operating Officer | 01/01/2017 | - |
Historique de carrière de Mic Iwashima
Formation de Mic Iwashima
| North Carolina State University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Satsuma Pharmaceuticals, Inc.
 Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraines. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company was founded by John Kollins on June 21, 2016 and is headquartered in Durham, NC. | Health Technology |
- Bourse
- Insiders
- Mic Iwashima
- Expérience
